OpportunityJOBPublic signal8 months ago
Founding Applied AI Engineer
Atlas Bio is hiring for this role on its own job board, after raising $11M.
Who they want
Approach preferences not yet specified
Atlas Bio
Atlas Bio is a developer of an AI foundation model for in silico clinical trials. From its funding announcement.
In their own words
What Atlas Bio says it is doing
Public signal Described in the funding announcement as "developer of an AI foundation model for in silico clinical trials". Source
Market expansionResearch and developmentCommercial growthPartnerships
Public signal Read from the company's own description of what the funding supports.
Why now
Where Atlas Bio is today
Atlas Bio announced a funding round of $11M on 2 November 2026, led by Creandum.
Latest round
Seed
Amount
$11M
Announced
2 November 2026
Headquarters
Berlin, Germany
Sector
Healthcare & Medtech
Investors
Also participating
First Momentum Ventures, LEA Partners
Relevant leadership
Not stated
Momentum AfterRaise intelligence
AfterRaise Score
62
Building momentum
1 funding signal in the last 90 days
Arriving with the signals layer
- Hiring momentum Open roles and hiring pace
- Market expansion New offices and new countries
- Leadership Executive appointments
- Product activity Launches and releases
Since the raise
What has happened since
- 2 November 2026$11M SeedLed by Creandum.
Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.
What may happen next
What this raise could create
AfterRaise intelligenceNot a statement of fact
What may happen next
- New market entry
- First local hires in the new market
- Local entity and legal setup
- Research programme expansion
Opportunities this could create
- Clinical hiring
- Provider partnerships
- Market-entry advisers
- Local employment infrastructure
- In-market partnerships
Based on the Healthcare & Medtech sector, a Seed round and the priorities the company itself set out. Not a statement of fact.
High momentum5 connected signals
- 2 November 2026$11M Seed announced
- 2 November 2026Stated priority: market expansion
- 2 November 2026Stated priority: research and development
- 2 November 2026Stated priority: commercial growth
- 2 November 2026Stated priority: partnerships
High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.
Open to
What Atlas Bio is open to
Not yet specified
Atlas Bio has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.
Work here? Set your preferencesOpportunities
Ways to work with Atlas Bio
Helpful contributors
People who have contributed here
Nobody yet
When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.
Do you work at Atlas Bio?
Claim your company profile.
This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.
What we do not have yet: who leads the team. Claiming the page is how you fill those in.
Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.
Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.
Also moving